Orin
APHNYSE·Hardware, Equipment & Parts

Amphenol Corporation

Market cap $193.8BP/E 37.2× trailingGross margin 38.5%
$78.21
+2.94 (+3.91%)Tue 27 Oct close 16:00 ET
52-wk $59.01 – $89.93
Orin's take
7out of 10 — how sure Orin is of this read

Orin's own judgment of how firmly the evidence points one way — not the chance the price goes up.

Refreshed 10 Oct, the 10th take on APH — written before the latest event Orin flagged. An update has been queued since 28 Oct and hasn't run yet.

Amphenol's FY2025 revenue grew 51.7% to $23.1B with operating margin expanding to 25.4% from 21.6%, and Q2 2026 sustained the momentum at $8.76B (+55% YoY) — but at 41.5x trailing P/E, APH trades at a 95.8% premium to the peer median of 21.2x, pricing in continued AI-driven hypergrowth.

Heavy insider selling ($858.6M net over 24 months as of the latest filings) and a doubling of total debt to $15.5B from $7.28B between FY2024 and FY2025 add caution, while smart money 13F flows are slightly negative (-0.02 as of Q2 2026). The company's execution is exceptional, but the risk/reward is balanced at these levels — hold for the AI connectivity exposure, but the premium limits margin of safety.

What could go wrong

  • Valuation premium. APH trades at 41.5x P/E and 7.4x P/S, a 95.8% and 124.4% premium to peer medians of 21.2x and 3.3x respectively, leaving limited room for execution missteps.
  • AI demand deceleration. FY2025 revenue growth of 51.7% and Q2 2026 YoY growth of 55% are heavily tied to AI infrastructure demand; any slowdown in hyperscaler capex could compress both growth and multiples.
  • Rising leverage. Total debt increased from $7.28B in FY2024 to $15.5B in FY2025, more than doubling year-over-year and raising financial risk if growth slows.
  • Persistent insider selling. Insiders net sold $858.6M of stock over 24 months with 207 transactions and only 1 acquisition, including option exercises and sales by the CFO and other EVPs in August 2026.

What would change my mind

Q3 2026 earnings. Q3 2026 results show revenue growth decelerating below 40% YoY or operating margin contractionbearish
AI capex commentary. Major hyperscalers signal reduced data-center infrastructure spending in 2027 guidancebearish
Margin reacceleration. Q3 2026 operating margin exceeds 26% with revenue above $9B, suggesting operating leverage is still expandingbullish
Insider buying reversal. Open-market insider purchases exceed $10M in aggregate over a 90-day windowbullish

Where this comes from: FY25 fundamentals · Q2 2026 results · peer comparison · FY24 and FY25 fundamentals. Orin's read on APH; not advice.

How has the share price moved?

27 Oct 2025 – 27 Oct 2026

Up 15.1% over twelve months, from $67.96 on 27 Oct 2025 to $78.21 at the Tue 27 Oct 2026 close. Its highest close in that time was $88.62 on 6 Oct 2026; the last close is 11.7% below it.

Jan 2026AprJulOct
    • Green line: the closing price each trading day.
    • Grey line: the average closing price over the last 50 trading days.
    • Dashed amber line: the same over the last 200 trading days — a slower, smoother line.
    • Bars along the bottom: shares traded each day — green when it closed higher than the day before, rose when lower (the most, 75.6M, on 28 Jan 2026).
    • Flags: the company's filings, on the day they were made (a 10-Q is the quarterly report and a 10-K the annual report; an 8-K reports a major event).
    • Rose flags: large share sales by the company's own officers and directors, from the Form 4 each one files after trading.

    Largest holders · 13F Q2 2026

    Money flow
    FilerPositionOf fund
    BlackRock$17.9B0.3%
    Vanguard Capital Management$14.2B0.3%
    FMR$12.4B0.5%
    State Street$10.5B0.3%
    JPMorgan Chase$6.5B0.4%
    Vanguard Portfolio Management$6.3B0.3%
    T. Rowe Price Associates$5.6B0.6%
    Geode Capital Management$5.5B0.3%
    Capital Research Global Investors$5.2B0.7%
    Morgan Stanley$3.6B0.2%

    162 of the 815 filers we track · quarter ended Q2 2026 · positions, not flows

    Insiders, last 24 months: 207 Form 4 filings; open-market trades net −$858.6M. Of the 50 on hand, 0 were open-market purchases and 9 sales — the rest are grants, option exercises and tax withholding.

    Ask Orin about APH

    its filings · its transcripts · its numbers

    Orin answers questions about APH from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.

    Start 3 free days →

    How is it priced, against its own past and its sector?

    Tue 27 Oct close

    Priced at 37.2× its last 12 months of profit (Tue 27 Oct close) — higher than in 4 of its last 5 fiscal years (middle 32.9×); the typical Technology company on the NYSE is at 39.5×.

    MeasureNowIts usualSector
    P/E37.2×above usual32.9×39.5×
    P/S6.65×above usual4.81×—
    EV/EBITDA22.4×near usual22.5×—
    P/B12.4×above usual8.3×—
    • "Its usual" is the middle of its own last 5 fiscal years.
    • A share split on 3 Sep changed the share count; figures from before it may not all be restated yet.

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    P/S: the company's total market value divided by one year of revenue. Used when there is no profit to measure.

    EV/EBITDA: the price of the whole company (its shares plus its debt, minus its cash) divided by one year of operating profit before interest, tax and write-downs.

    P/B: the share price divided by the book value per share — what the company owns minus what it owes, as its accounts record it. When book value is tiny, P/B swings wildly and says little.

    What do the analysts who cover it publish?

    12 firms rated it in the last 18 months · 27 Oct

    The analysts' average 12-month price target is $139 (from $99 to $215) — 78% above the Tue 27 Oct close price. That is their published opinion, not Orin's.

    Average price target

    $139

    $99 – $215 · +78% against the last close

    Their ratings
    • 11 buy or overweight
    • 1 hold
    • 0 underweight or sell

    Price target: the share price an analyst publishes for about 12 months ahead. It is the opinion of the firm that wrote it; the average is across the firms that cover the company.

    Overweight / underweight: analysts' rating words: overweight means the firm expects the stock to do better than the others it covers, underweight worse. Their words, not Orin's.

    How is it priced next to the companies it is compared to?

    middle P/E 21.9× · 3 of 3 with a profit

    Priced at 37.2× its last 12 months of profit; the middle P/E of the 3 companies it is compared to that made a profit is 21.9×.

    CompanyMarket valueP/EEV/EBITDAGross marginNet marginROE
    APHAmphenol Corporation$193B37.2×22.4×38.5%17.8%37%
    BDCBelden Inc.$4B17.3×10.6×36.5%8.5%19%
    GLWCorning Incorporated$109B50.5×24.2×36.4%12.1%17%
    TELTE Connectivity Ltd.$65B21.9×14.1×35.4%15.8%23%
    • The list of companies is the data vendor's choice, so it can include a company a person would not have picked.

    Market value: the share price times the number of shares — what the whole company is priced at.

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    EV/EBITDA: the price of the whole company (its shares plus its debt, minus its cash) divided by one year of operating profit before interest, tax and write-downs.

    Gross margin: the share of each $1 of sales left after the direct cost of making what was sold.

    Net margin: the share of each $1 of sales kept as profit after every cost. Below zero, the company lost money.

    ROE: return on equity: one year of profit as a share of the shareholders' money in the business (its book value).

    Is it priced high or low compared with its own past?

    Tue 27 Oct

    Priced at 37.2× its last 12 months of profit (Tue 27 Oct close). It has no full fiscal year on file since its history starts, so there is nothing of its own to compare with.

    • Now37.2×

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    Fiscal year (FY): the company's own 12-month accounting year, which need not match the calendar year.

    How has its sector been priced?

    Now–Now · Tue 27 Oct

    Technology companies on the NYSE were priced at a typical 39.5× their yearly profit (Tue 27 Oct close).

    • Now39.5×
    • Each year is the middle of that calendar year's daily sector P/E; "Now" is the Tue 27 Oct close figure, the same one in the table above.

    Sector P/E: the middle P/E of the companies in the same sector on the same stock exchange, as the data vendor works it out each day.

    What does a cash-flow model say a share is worth?

    computed 27 Oct at $77.92

    A standard cash-flow model puts it at $36 a share — 53% below the $77.92 price it was computed against (27 Oct).

    ModelValue a shareAgainst the price then
    Standard$3653% below $77.92
    Levered$4641% below $77.92
    • A share split on 3 Sep changed the share count; figures from before it may not all be restated yet.

    Discounted cash flow: a model's estimate of what the company is worth today, from the cash it is forecast to make in future years. Small changes in the forecast move it a lot, and it says little about a company that loses money.

    Standard / levered: two versions of the cash-flow model: the standard one counts the cash before the company pays its lenders, the levered one after.